Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.09913697 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.09913697 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.79064988 |
4 | L-phenylalanine metabolic process (GO:0006558) | 5.79064988 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.38125791 |
6 | indole-containing compound catabolic process (GO:0042436) | 4.76759864 |
7 | indolalkylamine catabolic process (GO:0046218) | 4.76759864 |
8 | tryptophan catabolic process (GO:0006569) | 4.76759864 |
9 | tryptophan metabolic process (GO:0006568) | 4.71281422 |
10 | COPI coating of Golgi vesicle (GO:0048205) | 4.57097201 |
11 | Golgi transport vesicle coating (GO:0048200) | 4.57097201 |
12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.48539457 |
13 | kynurenine metabolic process (GO:0070189) | 4.47180830 |
14 | glyoxylate metabolic process (GO:0046487) | 4.33095589 |
15 | sulfur amino acid catabolic process (GO:0000098) | 4.27648797 |
16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.26566023 |
17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.24639377 |
18 | protein carboxylation (GO:0018214) | 4.24639377 |
19 | cysteine metabolic process (GO:0006534) | 4.22194964 |
20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.21827642 |
21 | lysine metabolic process (GO:0006553) | 4.21434166 |
22 | lysine catabolic process (GO:0006554) | 4.21434166 |
23 | bile acid biosynthetic process (GO:0006699) | 4.19113424 |
24 | valine metabolic process (GO:0006573) | 4.11887813 |
25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.11316400 |
26 | intestinal cholesterol absorption (GO:0030299) | 4.03834909 |
27 | urea cycle (GO:0000050) | 3.97177698 |
28 | urea metabolic process (GO:0019627) | 3.97177698 |
29 | aromatic amino acid family metabolic process (GO:0009072) | 3.92542006 |
30 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.88449671 |
31 | complement activation, alternative pathway (GO:0006957) | 3.85354009 |
32 | signal peptide processing (GO:0006465) | 3.84828102 |
33 | tyrosine metabolic process (GO:0006570) | 3.83569987 |
34 | negative regulation of fibrinolysis (GO:0051918) | 3.83504574 |
35 | protein retention in ER lumen (GO:0006621) | 3.83082186 |
36 | homocysteine metabolic process (GO:0050667) | 3.82523130 |
37 | reverse cholesterol transport (GO:0043691) | 3.78912925 |
38 | alpha-linolenic acid metabolic process (GO:0036109) | 3.77949740 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 3.72712472 |
40 | regulation of protein activation cascade (GO:2000257) | 3.71042131 |
41 | nitrogen cycle metabolic process (GO:0071941) | 3.67186754 |
42 | bile acid metabolic process (GO:0008206) | 3.66525740 |
43 | regulation of fibrinolysis (GO:0051917) | 3.64851624 |
44 | cellular modified amino acid catabolic process (GO:0042219) | 3.63293191 |
45 | triglyceride homeostasis (GO:0070328) | 3.62641899 |
46 | acylglycerol homeostasis (GO:0055090) | 3.62641899 |
47 | ER overload response (GO:0006983) | 3.61056833 |
48 | alpha-amino acid catabolic process (GO:1901606) | 3.59765782 |
49 | indolalkylamine metabolic process (GO:0006586) | 3.55395230 |
50 | amino-acid betaine metabolic process (GO:0006577) | 3.51467776 |
51 | coenzyme catabolic process (GO:0009109) | 3.50773962 |
52 | phospholipid efflux (GO:0033700) | 3.49842765 |
53 | cellular glucuronidation (GO:0052695) | 3.48746594 |
54 | regulation of complement activation (GO:0030449) | 3.48691929 |
55 | plasma lipoprotein particle remodeling (GO:0034369) | 3.46953150 |
56 | protein-lipid complex remodeling (GO:0034368) | 3.46953150 |
57 | macromolecular complex remodeling (GO:0034367) | 3.46953150 |
58 | serine family amino acid catabolic process (GO:0009071) | 3.46809659 |
59 | regulation of cholesterol esterification (GO:0010872) | 3.46597478 |
60 | drug transmembrane transport (GO:0006855) | 3.44168169 |
61 | cellular amino acid catabolic process (GO:0009063) | 3.42260794 |
62 | amine catabolic process (GO:0009310) | 3.41309377 |
63 | cellular biogenic amine catabolic process (GO:0042402) | 3.41309377 |
64 | COPII vesicle coating (GO:0048208) | 3.41246348 |
65 | benzene-containing compound metabolic process (GO:0042537) | 3.40704037 |
66 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.40235551 |
67 | bile acid and bile salt transport (GO:0015721) | 3.38955151 |
68 | cellular ketone body metabolic process (GO:0046950) | 3.33005527 |
69 | fatty acid beta-oxidation (GO:0006635) | 3.31901988 |
70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.31666447 |
71 | complement activation, classical pathway (GO:0006958) | 3.29566967 |
72 | fatty acid oxidation (GO:0019395) | 3.27122092 |
73 | branched-chain amino acid metabolic process (GO:0009081) | 3.24295418 |
74 | phospholipid homeostasis (GO:0055091) | 3.22874169 |
75 | branched-chain amino acid catabolic process (GO:0009083) | 3.21379236 |
76 | regulation of cholesterol homeostasis (GO:2000188) | 3.20061772 |
77 | lipid oxidation (GO:0034440) | 3.19993689 |
78 | glucuronate metabolic process (GO:0019585) | 3.19628428 |
79 | uronic acid metabolic process (GO:0006063) | 3.19628428 |
80 | short-chain fatty acid metabolic process (GO:0046459) | 3.18766347 |
81 | hormone catabolic process (GO:0042447) | 3.17913359 |
82 | negative regulation of cholesterol transport (GO:0032375) | 3.17664814 |
83 | negative regulation of sterol transport (GO:0032372) | 3.17664814 |
84 | organic acid catabolic process (GO:0016054) | 3.15679348 |
85 | carboxylic acid catabolic process (GO:0046395) | 3.15679348 |
86 | monocarboxylic acid catabolic process (GO:0072329) | 3.12378738 |
87 | cholesterol efflux (GO:0033344) | 3.12283860 |
88 | fatty acid catabolic process (GO:0009062) | 3.11812995 |
89 | regulation of immunoglobulin secretion (GO:0051023) | 3.11610822 |
90 | complement activation (GO:0006956) | 3.11382095 |
91 | ethanol oxidation (GO:0006069) | 3.10097288 |
92 | aspartate family amino acid catabolic process (GO:0009068) | 3.04924458 |
93 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.99484084 |
94 | glutamate metabolic process (GO:0006536) | 2.98981179 |
95 | cofactor catabolic process (GO:0051187) | 2.97750660 |
96 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.94655469 |
97 | macroautophagy (GO:0016236) | 2.94627787 |
98 | protein activation cascade (GO:0072376) | 2.92874308 |
99 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.92825288 |
100 | exocrine pancreas development (GO:0031017) | 2.92575410 |
101 | 4-hydroxyproline metabolic process (GO:0019471) | 2.91613965 |
102 | plasma lipoprotein particle clearance (GO:0034381) | 2.91594744 |
103 | low-density lipoprotein particle remodeling (GO:0034374) | 2.90543730 |
104 | aldehyde catabolic process (GO:0046185) | 2.89638621 |
105 | drug catabolic process (GO:0042737) | 2.89482029 |
106 | oxaloacetate metabolic process (GO:0006107) | 2.89299588 |
107 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.88857167 |
108 | glycerophospholipid catabolic process (GO:0046475) | 2.86825624 |
109 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.84617999 |
110 | adaptation of signaling pathway (GO:0023058) | 2.83140901 |
111 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.81760417 |
112 | positive regulation of respiratory burst (GO:0060267) | 2.76806763 |
113 | cellular response to antibiotic (GO:0071236) | 2.74290527 |
114 | cellular response to glucose starvation (GO:0042149) | 2.74227034 |
115 | cellular response to type I interferon (GO:0071357) | 2.74159798 |
116 | type I interferon signaling pathway (GO:0060337) | 2.74159798 |
117 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.71601340 |
118 | response to type I interferon (GO:0034340) | 2.71317397 |
119 | regulation of regulatory T cell differentiation (GO:0045589) | 2.66162364 |
120 | cellular response to interleukin-15 (GO:0071350) | 2.63928768 |
121 | regulation of respiratory burst (GO:0060263) | 2.62144031 |
122 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.60943086 |
123 | positive regulation of defense response to virus by host (GO:0002230) | 2.59003450 |
124 | regulation of autophagic vacuole assembly (GO:2000785) | 2.57779378 |
125 | regulation of memory T cell differentiation (GO:0043380) | 2.57438054 |
126 | protein K11-linked deubiquitination (GO:0035871) | 2.57335401 |
127 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.57014551 |
128 | positive regulation of interleukin-12 production (GO:0032735) | 2.55556384 |
129 | negative regulation of bone resorption (GO:0045779) | 2.54837277 |
130 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.54446165 |
131 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.49783654 |
132 | positive regulation of protein homooligomerization (GO:0032464) | 2.48858856 |
133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.47439340 |
134 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.47260326 |
135 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.47178137 |
136 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.47028473 |
137 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46796624 |
138 | regulation of B cell apoptotic process (GO:0002902) | 2.46177048 |
139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.45088090 |
140 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.41408530 |
141 | * cellular response to unfolded protein (GO:0034620) | 2.37280249 |
142 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 2.36772066 |
143 | negative regulation of complement activation (GO:0045916) | 2.36647446 |
144 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.36002403 |
145 | regulation of germinal center formation (GO:0002634) | 2.33596166 |
146 | regulation of T-helper cell differentiation (GO:0045622) | 2.32908911 |
147 | positive regulation of glycolytic process (GO:0045821) | 2.32221919 |
148 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.31822023 |
149 | regulation of vacuole organization (GO:0044088) | 2.30423971 |
150 | negative regulation of protein activation cascade (GO:2000258) | 2.29578693 |
151 | negative regulation of acute inflammatory response (GO:0002674) | 2.29134197 |
152 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.28649210 |
153 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.28070428 |
154 | negative regulation of humoral immune response (GO:0002921) | 2.24682848 |
155 | * positive regulation of nuclease activity (GO:0032075) | 2.24274750 |
156 | serine transport (GO:0032329) | 2.21013034 |
157 | * cellular response to topologically incorrect protein (GO:0035967) | 2.20402413 |
158 | positive regulation of interferon-gamma production (GO:0032729) | 2.18436218 |
159 | positive regulation of interleukin-17 production (GO:0032740) | 2.18097463 |
160 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.17154930 |
161 | basic amino acid transport (GO:0015802) | 2.16792899 |
162 | cellular response to toxic substance (GO:0097237) | 2.14480261 |
163 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.12715246 |
164 | cellular response to ATP (GO:0071318) | 2.12419590 |
165 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.12403959 |
166 | positive regulation of autophagy (GO:0010508) | 2.12126204 |
167 | protein targeting to Golgi (GO:0000042) | 2.11982282 |
168 | * regulation of nuclease activity (GO:0032069) | 2.11385243 |
169 | ketone body metabolic process (GO:1902224) | 2.11302480 |
170 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.11187806 |
171 | cytidine deamination (GO:0009972) | 2.09777111 |
172 | cytidine metabolic process (GO:0046087) | 2.09777111 |
173 | cytidine catabolic process (GO:0006216) | 2.09777111 |
174 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.09276027 |
175 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.09034499 |
176 | regulation of hexokinase activity (GO:1903299) | 2.08401568 |
177 | regulation of glucokinase activity (GO:0033131) | 2.08401568 |
178 | platelet dense granule organization (GO:0060155) | 2.07970652 |
179 | * ER-nucleus signaling pathway (GO:0006984) | 2.07822595 |
180 | phenylpropanoid metabolic process (GO:0009698) | 2.07734279 |
181 | zinc ion transport (GO:0006829) | 2.07632915 |
182 | establishment of protein localization to Golgi (GO:0072600) | 2.06191831 |
183 | regulation of energy homeostasis (GO:2000505) | 2.05116694 |
184 | interferon-gamma production (GO:0032609) | 2.04094717 |
185 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.03856424 |
186 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.03351852 |
187 | immunoglobulin mediated immune response (GO:0016064) | 2.03056480 |
188 | regulation of defense response to virus by host (GO:0050691) | 2.02334571 |
189 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.02104301 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.70894805 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41948234 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.70618472 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.16472036 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.97572387 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.26731047 |
7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.24856812 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.77516722 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.54943171 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.36353166 |
11 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11174792 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.05148989 |
13 | GATA1_22025678_ChIP-Seq_K562_Human | 3.00562957 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.63002787 |
15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.57123918 |
16 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30236231 |
17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12770434 |
18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.09272772 |
19 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.02344711 |
20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92888960 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72869302 |
22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71813185 |
23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.69417376 |
24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66395691 |
25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.64084102 |
26 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.62562032 |
27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.57668746 |
28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53540122 |
29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48404213 |
30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45616660 |
31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45171343 |
32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39615953 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38823750 |
34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37097709 |
35 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35788656 |
36 | * MYB_26560356_Chip-Seq_TH2_Human | 1.34682439 |
37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.34019167 |
38 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.33744998 |
39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32033635 |
40 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30669965 |
41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30582630 |
42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30283902 |
43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30247107 |
44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29696795 |
45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29589965 |
46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28970189 |
47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.27316161 |
48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24651708 |
49 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.24100836 |
50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23885068 |
51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23630278 |
52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21935816 |
53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20336773 |
54 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.19432566 |
55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.19412065 |
56 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19397361 |
57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17469243 |
58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16700634 |
59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14522398 |
60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11409883 |
61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09801378 |
62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09611269 |
63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08976066 |
64 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08687892 |
65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08334207 |
66 | MYB_26560356_Chip-Seq_TH1_Human | 1.08138702 |
67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07909057 |
68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06858908 |
69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06196911 |
70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05849766 |
71 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03895829 |
72 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03180074 |
73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03015746 |
74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02630523 |
75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02616253 |
76 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01808448 |
77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01399325 |
78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00744253 |
79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00744253 |
80 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99212514 |
81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98508994 |
82 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98228665 |
83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97137160 |
84 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95086828 |
85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94496969 |
86 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93710761 |
87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93616222 |
88 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93399435 |
89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92796545 |
90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92294076 |
91 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.92140176 |
92 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91873295 |
93 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91646253 |
94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90698198 |
95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90111347 |
96 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88494944 |
97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88216051 |
98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87974227 |
99 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87685181 |
100 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.87378798 |
101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87346246 |
102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86767770 |
103 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86767770 |
104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86594160 |
105 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86494898 |
106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85798728 |
107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85468455 |
108 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.85048850 |
109 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.84956698 |
110 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.84296072 |
111 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.84296072 |
112 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83948424 |
113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83626532 |
114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83626532 |
115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83341936 |
116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83059860 |
117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83059860 |
118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81115082 |
119 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78795555 |
120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.78297758 |
121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78063679 |
122 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.77117530 |
123 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76968407 |
124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.76692382 |
125 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.76533237 |
126 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.76079687 |
127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75578393 |
128 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.74607245 |
129 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74329089 |
130 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73609405 |
131 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73400446 |
132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72667149 |
133 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.71679060 |
134 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71359495 |
135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71340220 |
136 | GATA3_26560356_Chip-Seq_TH2_Human | 0.70925594 |
137 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.70722437 |
138 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70482814 |
139 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70373278 |
140 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70307988 |
141 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70182181 |
142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69808818 |
143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68656138 |
144 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67021897 |
145 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.66883000 |
146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.66514180 |
147 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.66494987 |
148 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.66351849 |
149 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.63635739 |
150 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62673064 |
151 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.62515177 |
152 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62228588 |
153 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61744636 |
154 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60503912 |
155 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.60254035 |
156 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.59053730 |
157 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.58617648 |
158 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58605528 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.34781694 |
2 | MP0005360_urolithiasis | 5.22131505 |
3 | MP0005365_abnormal_bile_salt | 5.19124801 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.92024358 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.76457984 |
6 | MP0003195_calcinosis | 3.73166600 |
7 | MP0003252_abnormal_bile_duct | 3.41145401 |
8 | MP0001666_abnormal_nutrient_absorption | 3.01860146 |
9 | MP0002138_abnormal_hepatobiliary_system | 2.89651905 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.83159110 |
11 | MP0005083_abnormal_biliary_tract | 2.76901462 |
12 | MP0010329_abnormal_lipoprotein_level | 2.59265559 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.34951561 |
14 | MP0005332_abnormal_amino_acid | 2.34240172 |
15 | MP0009840_abnormal_foam_cell | 2.22831967 |
16 | MP0005671_abnormal_response_to | 2.22520376 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.16503329 |
18 | MP0003011_delayed_dark_adaptation | 2.10642258 |
19 | MP0005220_abnormal_exocrine_pancreas | 2.07945667 |
20 | MP0005000_abnormal_immune_tolerance | 2.07280067 |
21 | MP0002877_abnormal_melanocyte_morpholog | 2.03277430 |
22 | MP0003950_abnormal_plasma_membrane | 2.02574011 |
23 | MP0004043_abnormal_pH_regulation | 2.01263351 |
24 | MP0003868_abnormal_feces_composition | 1.92300367 |
25 | MP0000609_abnormal_liver_physiology | 1.89094570 |
26 | MP0009643_abnormal_urine_homeostasis | 1.87457077 |
27 | MP0002163_abnormal_gland_morphology | 1.85389496 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.80594173 |
29 | MP0002723_abnormal_immune_serum | 1.73466723 |
30 | MP0002452_abnormal_antigen_presenting | 1.70047288 |
31 | MP0005319_abnormal_enzyme/_coenzyme | 1.69369264 |
32 | MP0004019_abnormal_vitamin_homeostasis | 1.68052660 |
33 | MP0001764_abnormal_homeostasis | 1.64938636 |
34 | MP0001986_abnormal_taste_sensitivity | 1.63992915 |
35 | MP0001501_abnormal_sleep_pattern | 1.58704911 |
36 | MP0003045_fibrosis | 1.57795828 |
37 | MP0002693_abnormal_pancreas_physiology | 1.54806629 |
38 | MP0003763_abnormal_thymus_physiology | 1.47983412 |
39 | MP0002006_tumorigenesis | 1.42731932 |
40 | MP0002420_abnormal_adaptive_immunity | 1.41409049 |
41 | MP0001819_abnormal_immune_cell | 1.39227022 |
42 | MP0008872_abnormal_physiological_respon | 1.37870768 |
43 | MP0005084_abnormal_gallbladder_morpholo | 1.37093902 |
44 | MP0001944_abnormal_pancreas_morphology | 1.36060297 |
45 | MP0002876_abnormal_thyroid_physiology | 1.36017905 |
46 | MP0002837_dystrophic_cardiac_calcinosis | 1.35783486 |
47 | MP0004782_abnormal_surfactant_physiolog | 1.33838085 |
48 | MP0002078_abnormal_glucose_homeostasis | 1.33016558 |
49 | MP0003186_abnormal_redox_activity | 1.32706613 |
50 | MP0005636_abnormal_mineral_homeostasis | 1.29139701 |
51 | MP0002928_abnormal_bile_duct | 1.28568310 |
52 | MP0003183_abnormal_peptide_metabolism | 1.24069477 |
53 | MP0002405_respiratory_system_inflammati | 1.22989227 |
54 | MP0005670_abnormal_white_adipose | 1.22519010 |
55 | MP0003300_gastrointestinal_ulcer | 1.20730726 |
56 | MP0001835_abnormal_antigen_presentation | 1.20544923 |
57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20539860 |
58 | MP0003303_peritoneal_inflammation | 1.19687587 |
59 | MP0003656_abnormal_erythrocyte_physiolo | 1.19192257 |
60 | MP0004264_abnormal_extraembryonic_tissu | 1.18775334 |
61 | MP0005058_abnormal_lysosome_morphology | 1.17497839 |
62 | MP0009697_abnormal_copulation | 1.16840618 |
63 | MP0005645_abnormal_hypothalamus_physiol | 1.16447805 |
64 | MP0005164_abnormal_response_to | 1.16201547 |
65 | MP0000372_irregular_coat_pigmentation | 1.16095470 |
66 | MP0003436_decreased_susceptibility_to | 1.13922304 |
67 | MP0008469_abnormal_protein_level | 1.12001078 |
68 | MP0001756_abnormal_urination | 1.10897682 |
69 | MP0002933_joint_inflammation | 1.09759041 |
70 | MP0009764_decreased_sensitivity_to | 1.07867305 |
71 | MP0000598_abnormal_liver_morphology | 1.06397658 |
72 | MP0005551_abnormal_eye_electrophysiolog | 1.05996676 |
73 | MP0000716_abnormal_immune_system | 1.00506384 |
74 | MP0002102_abnormal_ear_morphology | 0.98806810 |
75 | MP0001765_abnormal_ion_homeostasis | 0.98378291 |
76 | MP0009780_abnormal_chondrocyte_physiolo | 0.96322056 |
77 | MP0009642_abnormal_blood_homeostasis | 0.96213681 |
78 | MP0010386_abnormal_urinary_bladder | 0.96052400 |
79 | MP0003724_increased_susceptibility_to | 0.95226286 |
80 | MP0005647_abnormal_sex_gland | 0.93290773 |
81 | MP0006036_abnormal_mitochondrial_physio | 0.92148909 |
82 | MP0002254_reproductive_system_inflammat | 0.92121360 |
83 | MP0001542_abnormal_bone_strength | 0.92103636 |
84 | MP0005408_hypopigmentation | 0.90991653 |
85 | MP0000569_abnormal_digit_pigmentation | 0.90448395 |
86 | MP0005535_abnormal_body_temperature | 0.89956518 |
87 | MP0003866_abnormal_defecation | 0.89463748 |
88 | MP0000015_abnormal_ear_pigmentation | 0.89066463 |
89 | MP0002136_abnormal_kidney_physiology | 0.88687055 |
90 | MP0001845_abnormal_inflammatory_respons | 0.88380831 |
91 | MP0000604_amyloidosis | 0.87773427 |
92 | MP0000689_abnormal_spleen_morphology | 0.87014532 |
93 | MP0006072_abnormal_retinal_apoptosis | 0.86365164 |
94 | MP0009763_increased_sensitivity_to | 0.85283428 |
95 | MP0002398_abnormal_bone_marrow | 0.84664499 |
96 | MP0000465_gastrointestinal_hemorrhage | 0.84300566 |
97 | MP0005451_abnormal_body_composition | 0.83718237 |
98 | MP0002332_abnormal_exercise_endurance | 0.82593493 |
99 | MP0002295_abnormal_pulmonary_circulatio | 0.82522060 |
100 | MP0005334_abnormal_fat_pad | 0.82328171 |
101 | MP0010368_abnormal_lymphatic_system | 0.81507347 |
102 | MP0005464_abnormal_platelet_physiology | 0.79826174 |
103 | MP0004947_skin_inflammation | 0.78645615 |
104 | MP0004883_abnormal_blood_vessel | 0.78218688 |
105 | MP0009765_abnormal_xenobiotic_induced | 0.78012327 |
106 | MP0000013_abnormal_adipose_tissue | 0.77397294 |
107 | MP0002090_abnormal_vision | 0.76325153 |
108 | MP0003953_abnormal_hormone_level | 0.75390290 |
109 | MP0002909_abnormal_adrenal_gland | 0.74349448 |
110 | MP0005387_immune_system_phenotype | 0.72709908 |
111 | MP0001790_abnormal_immune_system | 0.72709908 |
112 | MP0005310_abnormal_salivary_gland | 0.72168110 |
113 | MP0002166_altered_tumor_susceptibility | 0.71910575 |
114 | MP0000230_abnormal_systemic_arterial | 0.70554256 |
115 | MP0009785_altered_susceptibility_to | 0.70381372 |
116 | MP0002419_abnormal_innate_immunity | 0.69452111 |
117 | MP0005376_homeostasis/metabolism_phenot | 0.68728378 |
118 | MP0005448_abnormal_energy_balance | 0.67857812 |
119 | MP0001853_heart_inflammation | 0.67550473 |
120 | MP0000678_abnormal_parathyroid_gland | 0.63942224 |
121 | MP0006054_spinal_hemorrhage | 0.60890822 |
122 | MP0005025_abnormal_response_to | 0.60589305 |
123 | MP0001533_abnormal_skeleton_physiology | 0.60251593 |
124 | MP0010155_abnormal_intestine_physiology | 0.58969393 |
125 | MP0003959_abnormal_lean_body | 0.58027343 |
126 | MP0000538_abnormal_urinary_bladder | 0.57935022 |
127 | MP0003638_abnormal_response/metabolism_ | 0.57883190 |
128 | MP0003172_abnormal_lysosome_physiology | 0.57593034 |
129 | MP0005379_endocrine/exocrine_gland_phen | 0.57585834 |
130 | MP0006082_CNS_inflammation | 0.57400879 |
131 | MP0000003_abnormal_adipose_tissue | 0.57273806 |
132 | MP0000613_abnormal_salivary_gland | 0.57217530 |
133 | MP0002896_abnormal_bone_mineralization | 0.56201914 |
134 | MP0000685_abnormal_immune_system | 0.54533786 |
135 | MP0001873_stomach_inflammation | 0.54270846 |
136 | MP0010234_abnormal_vibrissa_follicle | 0.53508625 |
137 | MP0002168_other_aberrant_phenotype | 0.53343026 |
138 | MP0001800_abnormal_humoral_immune | 0.52885638 |
139 | MP0003075_altered_response_to | 0.52145521 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.93026379 |
2 | Hypoglycemic coma (HP:0001325) | 5.06547537 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.97089335 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 4.73397753 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.70029081 |
6 | Deep venous thrombosis (HP:0002625) | 4.43588888 |
7 | Xanthomatosis (HP:0000991) | 4.32528946 |
8 | Abnormality of the intrinsic pathway (HP:0010989) | 4.32188393 |
9 | Ketosis (HP:0001946) | 4.24422469 |
10 | Hypoglycemic seizures (HP:0002173) | 4.03892190 |
11 | Ketoacidosis (HP:0001993) | 4.02480119 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 3.95643277 |
13 | Complement deficiency (HP:0004431) | 3.89666100 |
14 | Generalized aminoaciduria (HP:0002909) | 3.83934026 |
15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.76093601 |
16 | Hypobetalipoproteinemia (HP:0003563) | 3.74031670 |
17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63452784 |
18 | Fat malabsorption (HP:0002630) | 3.61398154 |
19 | Gout (HP:0001997) | 3.57637147 |
20 | Joint hemorrhage (HP:0005261) | 3.57605695 |
21 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47278606 |
22 | Chronic diarrhea (HP:0002028) | 3.45079067 |
23 | Hyperammonemia (HP:0001987) | 3.40633644 |
24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.38659099 |
25 | Hyperlipoproteinemia (HP:0010980) | 3.38306274 |
26 | Hyperglycinuria (HP:0003108) | 3.28795602 |
27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28647862 |
28 | Symptomatic seizures (HP:0011145) | 3.23162742 |
29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.13951869 |
30 | Abnormality of purine metabolism (HP:0004352) | 3.11277965 |
31 | Metaphyseal dysplasia (HP:0100255) | 3.08020910 |
32 | Late onset (HP:0003584) | 3.03046030 |
33 | Hypolipoproteinemia (HP:0010981) | 3.01308710 |
34 | Chronic hepatic failure (HP:0100626) | 3.00703437 |
35 | Hyperglycemia (HP:0003074) | 2.98487803 |
36 | Abnormality of complement system (HP:0005339) | 2.95033680 |
37 | Hyperglycinemia (HP:0002154) | 2.94246379 |
38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.93399606 |
39 | Abnormality of glycine metabolism (HP:0010895) | 2.93399606 |
40 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.91352572 |
41 | Recurrent bronchitis (HP:0002837) | 2.91171579 |
42 | Steatorrhea (HP:0002570) | 2.89795998 |
43 | Hyperbilirubinemia (HP:0002904) | 2.89734035 |
44 | Hypoalphalipoproteinemia (HP:0003233) | 2.83416206 |
45 | Epidermoid cyst (HP:0200040) | 2.82231860 |
46 | Abnormality of methionine metabolism (HP:0010901) | 2.79172862 |
47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77784088 |
48 | Hypothermia (HP:0002045) | 2.76349469 |
49 | Systemic lupus erythematosus (HP:0002725) | 2.75614656 |
50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.72160259 |
51 | Gastrointestinal stroma tumor (HP:0100723) | 2.71473174 |
52 | Albinism (HP:0001022) | 2.63736406 |
53 | Myocardial infarction (HP:0001658) | 2.61612205 |
54 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.60846657 |
55 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.60846657 |
56 | Pulmonary infiltrates (HP:0002113) | 2.60119216 |
57 | Dicarboxylic aciduria (HP:0003215) | 2.58149379 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58149379 |
59 | Decreased circulating renin level (HP:0003351) | 2.56144357 |
60 | Vasculitis (HP:0002633) | 2.55881289 |
61 | Metabolic acidosis (HP:0001942) | 2.53442091 |
62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52860118 |
63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52860118 |
64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52860118 |
65 | IgG deficiency (HP:0004315) | 2.50612292 |
66 | Malnutrition (HP:0004395) | 2.48639231 |
67 | Abnormal albumin level (HP:0012116) | 2.48149483 |
68 | Hypoalbuminemia (HP:0003073) | 2.48149483 |
69 | Thyroiditis (HP:0100646) | 2.47997671 |
70 | Agammaglobulinemia (HP:0004432) | 2.47848067 |
71 | Pancreatitis (HP:0001733) | 2.47352117 |
72 | Proximal tubulopathy (HP:0000114) | 2.45802254 |
73 | Recurrent sinusitis (HP:0011108) | 2.44708139 |
74 | Stomatitis (HP:0010280) | 2.43537258 |
75 | Exocrine pancreatic insufficiency (HP:0001738) | 2.41377105 |
76 | Vascular calcification (HP:0004934) | 2.41152830 |
77 | Large for gestational age (HP:0001520) | 2.40913165 |
78 | Hypoplasia of the odontoid process (HP:0003311) | 2.39285519 |
79 | Hepatocellular carcinoma (HP:0001402) | 2.31217505 |
80 | Methylmalonic aciduria (HP:0012120) | 2.29330963 |
81 | Glomerulonephritis (HP:0000099) | 2.28672684 |
82 | Hypokalemic alkalosis (HP:0001949) | 2.28285182 |
83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26895012 |
84 | Barrel-shaped chest (HP:0001552) | 2.26343842 |
85 | Vacuolated lymphocytes (HP:0001922) | 2.26172263 |
86 | Glycosuria (HP:0003076) | 2.23725754 |
87 | Abnormality of urine glucose concentration (HP:0011016) | 2.23725754 |
88 | Hyperuricemia (HP:0002149) | 2.20729956 |
89 | Increased purine levels (HP:0004368) | 2.20729956 |
90 | Enlarged kidneys (HP:0000105) | 2.20247478 |
91 | Abnormality of T cell physiology (HP:0011840) | 2.19707673 |
92 | Mitral stenosis (HP:0001718) | 2.16596324 |
93 | Skin nodule (HP:0200036) | 2.16311503 |
94 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15516580 |
95 | Hypercholesterolemia (HP:0003124) | 2.14700776 |
96 | Acute hepatic failure (HP:0006554) | 2.14620447 |
97 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.13120803 |
98 | Abnormality of vitamin B metabolism (HP:0004340) | 2.11815582 |
99 | Abnormality of proline metabolism (HP:0010907) | 2.11430088 |
100 | Hydroxyprolinuria (HP:0003080) | 2.11430088 |
101 | Cardiovascular calcification (HP:0011915) | 2.11397567 |
102 | Optic neuritis (HP:0100653) | 2.11392882 |
103 | Retrobulbar optic neuritis (HP:0100654) | 2.11392882 |
104 | Abnormal tarsal ossification (HP:0008369) | 2.11380220 |
105 | Abnormal gallbladder morphology (HP:0012437) | 2.11231448 |
106 | Fetal akinesia sequence (HP:0001989) | 2.10884298 |
107 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10796334 |
108 | Hyperactive renin-angiotensin system (HP:0000841) | 2.10002029 |
109 | Tetraparesis (HP:0002273) | 2.09675099 |
110 | Hand muscle atrophy (HP:0009130) | 2.09126906 |
111 | Opisthotonus (HP:0002179) | 2.08663088 |
112 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08542831 |
113 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08542831 |
114 | Abnormality of serum amino acid levels (HP:0003112) | 2.08466818 |
115 | Upper limb muscle weakness (HP:0003484) | 2.08432007 |
116 | Lethargy (HP:0001254) | 2.08332197 |
117 | Alkalosis (HP:0001948) | 2.08030214 |
118 | IgA deficiency (HP:0002720) | 2.06156459 |
119 | Protuberant abdomen (HP:0001538) | 2.06071452 |
120 | Hemoptysis (HP:0002105) | 2.06055863 |
121 | Mucopolysacchariduria (HP:0008155) | 2.04008500 |
122 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04008500 |
123 | Congenital sensorineural hearing impairment (HP:0008527) | 2.03602393 |
124 | Emphysema (HP:0002097) | 2.02403214 |
125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.02175931 |
126 | Lymphopenia (HP:0001888) | 2.01942023 |
127 | Aplasia of the musculature (HP:0100854) | 2.00349921 |
128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99245276 |
129 | Abnormal pancreas size (HP:0012094) | 1.98958200 |
130 | Menorrhagia (HP:0000132) | 1.98325802 |
131 | Autoimmune hemolytic anemia (HP:0001890) | 1.97976166 |
132 | Renal cortical cysts (HP:0000803) | 1.97771483 |
133 | Chronic sinusitis (HP:0011109) | 1.97698704 |
134 | Vomiting (HP:0002013) | 1.97271508 |
135 | Increased CSF protein (HP:0002922) | 1.97039282 |
136 | Elevated alkaline phosphatase (HP:0003155) | 1.93159489 |
137 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92945325 |
138 | Meningitis (HP:0001287) | 1.92517531 |
139 | Bronchitis (HP:0012387) | 1.91690748 |
140 | Follicular hyperkeratosis (HP:0007502) | 1.90624883 |
141 | Hematochezia (HP:0002573) | 1.89590663 |
142 | Elevated hepatic transaminases (HP:0002910) | 1.89092245 |
143 | Carpal bone hypoplasia (HP:0001498) | 1.88933436 |
144 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88821228 |
145 | Lower limb hyperreflexia (HP:0002395) | 1.87471352 |
146 | Cerebral edema (HP:0002181) | 1.87005129 |
147 | Irritability (HP:0000737) | 1.87000229 |
148 | Myoglobinuria (HP:0002913) | 1.86708827 |
149 | Insulin resistance (HP:0000855) | 1.86090110 |
150 | Abnormal foot bone ossification (HP:0010675) | 1.84315319 |
151 | Orchitis (HP:0100796) | 1.83567211 |
152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83087946 |
153 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83087946 |
154 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83087946 |
155 | Dysostosis multiplex (HP:0000943) | 1.82754139 |
156 | Reduced antithrombin III activity (HP:0001976) | 1.82476052 |
157 | Delayed CNS myelination (HP:0002188) | 1.82399086 |
158 | Hemiparesis (HP:0001269) | 1.81766586 |
159 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81430076 |
160 | Keratoconjunctivitis (HP:0001096) | 1.81397289 |
161 | Keratitis (HP:0000491) | 1.81296997 |
162 | Skin rash (HP:0000988) | 1.81287557 |
163 | Abnormality of the pleura (HP:0002103) | 1.79153537 |
164 | Global brain atrophy (HP:0002283) | 1.78713483 |
165 | Tongue fasciculations (HP:0001308) | 1.77627244 |
166 | Hip dysplasia (HP:0001385) | 1.74148451 |
167 | Abnormality of the prostate (HP:0008775) | 1.73690905 |
168 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.72515524 |
169 | Methylmalonic acidemia (HP:0002912) | 1.71714294 |
170 | Neutropenia (HP:0001875) | 1.71651141 |
171 | Nonprogressive disorder (HP:0003680) | 1.70849481 |
172 | Popliteal pterygium (HP:0009756) | 1.67439508 |
173 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.65682616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 5.64267261 |
2 | BCKDK | 4.94117775 |
3 | INSRR | 3.90248215 |
4 | TAOK3 | 3.28036620 |
5 | FRK | 2.98896220 |
6 | IRAK3 | 2.72114502 |
7 | MAP3K14 | 2.63584650 |
8 | MAPK15 | 2.53583410 |
9 | FLT3 | 2.43968003 |
10 | PIK3CG | 2.36559753 |
11 | SIK3 | 2.06217368 |
12 | FGFR4 | 2.00882044 |
13 | SIK1 | 1.96240041 |
14 | MUSK | 1.90129527 |
15 | MAP3K12 | 1.81215613 |
16 | MAP4K2 | 1.79603895 |
17 | MAP3K3 | 1.79215757 |
18 | TBK1 | 1.67246670 |
19 | OXSR1 | 1.66570829 |
20 | PAK3 | 1.66098516 |
21 | TYK2 | 1.66007059 |
22 | FER | 1.65390969 |
23 | AKT3 | 1.63345620 |
24 | IKBKE | 1.45512546 |
25 | TGFBR2 | 1.44857000 |
26 | TRIB3 | 1.40207767 |
27 | MAP3K13 | 1.39766665 |
28 | IRAK4 | 1.33740820 |
29 | EPHA3 | 1.31835309 |
30 | NEK9 | 1.31292407 |
31 | JAK1 | 1.29142251 |
32 | PDK2 | 1.28860082 |
33 | PKN2 | 1.28517148 |
34 | ACVR1B | 1.26276842 |
35 | WNK4 | 1.23836442 |
36 | STK39 | 1.23742125 |
37 | EIF2AK3 | 1.18384542 |
38 | ADRBK2 | 1.14241546 |
39 | ZAP70 | 1.12260781 |
40 | PASK | 1.10674609 |
41 | MST1R | 1.04489502 |
42 | IKBKB | 1.02396540 |
43 | MAP3K2 | 1.01827086 |
44 | RIPK1 | 1.00715204 |
45 | PTK6 | 0.98568422 |
46 | JAK3 | 0.97860576 |
47 | CHUK | 0.96688137 |
48 | MAP2K2 | 0.96497947 |
49 | MAP2K3 | 0.96355798 |
50 | RIPK4 | 0.94017060 |
51 | STK38L | 0.92889203 |
52 | PRKD2 | 0.92754328 |
53 | IRAK1 | 0.92062239 |
54 | PIM2 | 0.91670466 |
55 | HIPK2 | 0.90871508 |
56 | SGK2 | 0.89907665 |
57 | JAK2 | 0.89021283 |
58 | MYLK | 0.86797029 |
59 | PRKCE | 0.85629006 |
60 | MAP3K10 | 0.85280988 |
61 | NLK | 0.85181431 |
62 | MAP4K1 | 0.84139947 |
63 | SGK3 | 0.80847969 |
64 | TIE1 | 0.80753607 |
65 | BMPR1B | 0.79505019 |
66 | MAPK11 | 0.78853405 |
67 | PRKAA2 | 0.74385884 |
68 | MAPKAPK3 | 0.72434230 |
69 | PIK3CA | 0.69433244 |
70 | GRK7 | 0.69367832 |
71 | FGFR3 | 0.66718874 |
72 | BTK | 0.64406924 |
73 | ERBB4 | 0.64394244 |
74 | FES | 0.64245420 |
75 | MAPK7 | 0.64111356 |
76 | LIMK1 | 0.63570359 |
77 | CSF1R | 0.63228217 |
78 | PDK1 | 0.61707642 |
79 | WNK3 | 0.61215324 |
80 | PHKG2 | 0.61086094 |
81 | PHKG1 | 0.61086094 |
82 | ARAF | 0.60876408 |
83 | BCR | 0.60695598 |
84 | PRKCI | 0.59791419 |
85 | PTK2B | 0.59059211 |
86 | SIK2 | 0.58727272 |
87 | TEC | 0.58283881 |
88 | DYRK1B | 0.56860084 |
89 | ITK | 0.56370647 |
90 | RPS6KA2 | 0.56291746 |
91 | BMPR2 | 0.55060739 |
92 | PRKG2 | 0.54710995 |
93 | ABL1 | 0.54115827 |
94 | GRK6 | 0.54083159 |
95 | HCK | 0.53355496 |
96 | KIT | 0.52192249 |
97 | TNK2 | 0.51254209 |
98 | BRSK2 | 0.50539128 |
99 | RAF1 | 0.50365277 |
100 | PINK1 | 0.48936510 |
101 | ERBB3 | 0.46829659 |
102 | PRKAA1 | 0.46807003 |
103 | CDC42BPA | 0.46547883 |
104 | MAP3K1 | 0.46512538 |
105 | MAP3K5 | 0.45485283 |
106 | CSK | 0.43955944 |
107 | SGK223 | 0.43392156 |
108 | SGK494 | 0.43392156 |
109 | SYK | 0.42434122 |
110 | RPS6KA6 | 0.42098898 |
111 | TTN | 0.41485629 |
112 | GSK3A | 0.41071736 |
113 | LATS1 | 0.40750386 |
114 | NUAK1 | 0.40102131 |
115 | LCK | 0.39811372 |
116 | EPHB1 | 0.39507769 |
117 | ZAK | 0.39085629 |
118 | MAPK12 | 0.38466870 |
119 | RPS6KL1 | 0.38383740 |
120 | RPS6KC1 | 0.38383740 |
121 | MST4 | 0.38296407 |
122 | PRKCH | 0.38099441 |
123 | RPS6KA5 | 0.38043216 |
124 | TXK | 0.36157827 |
125 | BLK | 0.35137930 |
126 | MARK3 | 0.34724936 |
127 | RPS6KB1 | 0.34603878 |
128 | GRK1 | 0.34584670 |
129 | IGF1R | 0.34577065 |
130 | PRKCD | 0.33541021 |
131 | TLK1 | 0.33459025 |
132 | LYN | 0.32259268 |
133 | MAP3K7 | 0.32198066 |
134 | PRKACG | 0.31538045 |
135 | MAP2K1 | 0.30129891 |
136 | MAPKAPK2 | 0.29876003 |
137 | IRAK2 | 0.29720707 |
138 | PRKCQ | 0.29701001 |
139 | STK24 | 0.29333099 |
140 | PDPK1 | 0.28981906 |
141 | TRPM7 | 0.28877191 |
142 | RPS6KA4 | 0.28571507 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.52764788 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.51694654 |
3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.38722809 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10892218 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 2.99676915 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96083022 |
7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.84591044 |
8 | Asthma_Homo sapiens_hsa05310 | 2.81140249 |
9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.74213959 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64170984 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56850060 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54881852 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.52319491 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.48797512 |
15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.47896361 |
16 | Protein export_Homo sapiens_hsa03060 | 2.39538065 |
17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24561765 |
18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.16264236 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.08011691 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03029672 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00496913 |
22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99227331 |
23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.97294555 |
24 | Peroxisome_Homo sapiens_hsa04146 | 1.97216602 |
25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.87277171 |
26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.86141397 |
27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84189744 |
28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.81931245 |
29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.77739808 |
30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75865641 |
31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.68653154 |
32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65780213 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64334804 |
34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62253627 |
35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61943122 |
36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59892005 |
37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59332303 |
38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54194831 |
39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49378103 |
40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49065226 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48740436 |
42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.47792062 |
43 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42480937 |
44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39021416 |
45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37304468 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.37222470 |
47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35086998 |
48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34936509 |
49 | ABC transporters_Homo sapiens_hsa02010 | 1.30148779 |
50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26957149 |
51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23198109 |
52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20154833 |
53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19316219 |
54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16920872 |
55 | Mineral absorption_Homo sapiens_hsa04978 | 1.15980651 |
56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14921926 |
57 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05616974 |
58 | Bile secretion_Homo sapiens_hsa04976 | 1.05214772 |
59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03725294 |
60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01429374 |
61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00264664 |
62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99226035 |
63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94257700 |
64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93546288 |
65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93165384 |
66 | Influenza A_Homo sapiens_hsa05164 | 0.93093622 |
67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92889812 |
68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.91947037 |
69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91694265 |
70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89526918 |
71 | Measles_Homo sapiens_hsa05162 | 0.89085544 |
72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89052727 |
73 | Tuberculosis_Homo sapiens_hsa05152 | 0.88445576 |
74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85688797 |
75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84912144 |
76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82801262 |
77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82659198 |
78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81956244 |
79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81467340 |
80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78381936 |
81 | Lysine degradation_Homo sapiens_hsa00310 | 0.75855888 |
82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75303070 |
83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74076037 |
84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72917318 |
85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72455355 |
86 | Phototransduction_Homo sapiens_hsa04744 | 0.71539362 |
87 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70991319 |
88 | Insulin resistance_Homo sapiens_hsa04931 | 0.70382428 |
89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69100586 |
90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67506067 |
91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67076827 |
92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66365166 |
93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65399750 |
94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64317120 |
95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64188940 |
96 | Pertussis_Homo sapiens_hsa05133 | 0.64138422 |
97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64115390 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62796904 |
99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58948555 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58289389 |
101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58254449 |
102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57731096 |
103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56070343 |
104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54723277 |
105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52977983 |
106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52290229 |
107 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51352544 |
108 | Phagosome_Homo sapiens_hsa04145 | 0.51136973 |
109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50021350 |
110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49719714 |
111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49248419 |
112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49191675 |
113 | Insulin secretion_Homo sapiens_hsa04911 | 0.47477977 |
114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46978091 |
115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46875185 |
116 | Lysosome_Homo sapiens_hsa04142 | 0.46861475 |
117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44578111 |
118 | Prion diseases_Homo sapiens_hsa05020 | 0.43816711 |
119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41418013 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40078910 |
121 | Legionellosis_Homo sapiens_hsa05134 | 0.39902635 |
122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38450259 |
123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34205676 |
124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33312570 |
125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31170390 |
126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26694390 |
127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24136581 |
128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23636826 |
129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22340421 |
130 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.19857918 |
131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17814331 |
132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.17746075 |
133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17539498 |
134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17023025 |
135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16887728 |
136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16483894 |
137 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16249343 |
138 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15135347 |
139 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14930002 |
140 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.11476790 |
141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10754160 |
142 | Hepatitis C_Homo sapiens_hsa05160 | 0.10393125 |